Contact the Editorial Desk

Editorial correspondence

TSMMA Peptides welcomes correspondence on the research record: a citation we have quoted inaccurately, a regulatory status that has changed, or a peer-reviewed study about MOTS-c or tesamorelin that should be added to the references page. Corrections that improve accuracy are the most useful messages this desk receives, and they are read carefully.

The most actionable notes specify three things: the page in question, the exact passage, and the supporting citation — a DOI or PubMed ID wherever possible. That allows a proposed change to be verified against the source quickly.

Editorial mailbox: editors@tsmmapeptides.com

What this desk cannot do

So that no message goes unanswered for the wrong reason, a few things fall outside what this site can address. TSMMA Peptides is a literature digest, not a clinic or a vendor, so we cannot:

• Advise on, recommend, or comment on human use of any peptide discussed here.
• Suggest a dose, schedule, or route of administration for any individual.
• Diagnose a condition or judge whether a particular research finding applies to a particular person.
• Sell, source, recommend, or help locate any compound from any supplier.
• Answer requests from athletes subject to anti-doping rules about whether or how to use these peptides, given that both are prohibited in sport.

Readers seeking medical guidance should consult a licensed clinician in their own jurisdiction. Responses to editorial correspondence are not guaranteed and may take time; the mailbox is monitored periodically.